Growth Metrics

Dexcom (DXCM) EBT Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.50%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.26%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -8.83%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 5.78%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 103.34%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 74.66%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -27.02%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 54.33%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 31.57%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 74.66%
Dec 31, 2025 61.24%
Sep 30, 2025 98.59%
Jun 30, 2025 28.38%
Mar 31, 2025 16.45%
Dec 31, 2024 -14.18%
Sep 30, 2024 -26.21%
Jun 30, 2024 17.89%
Mar 31, 2024 105.43%
Dec 31, 2023 84.83%
Sep 30, 2023 64.43%
Jun 30, 2023 111.55%
Mar 31, 2023 78.67%
Dec 31, 2022 1,981.25%
Sep 30, 2022 30.54%
Jun 30, 2022 -22.45%
Mar 31, 2022 -12.59%
Dec 31, 2021 -95.85%
Sep 30, 2021 49.13%
Jun 30, 2021 110.17%
Mar 31, 2021 84.38%
Dec 31, 2020 63.52%
Sep 30, 2020 63.97%
Jun 30, 2020 596.77%
Mar 31, 2020 184.21%
Dec 31, 2019 153.31%
Sep 30, 2019 2.23%
Jun 30, 2019 -131.42%
Mar 31, 2019 -10.83%
Dec 31, 2018 -2,156.98%
Sep 30, 2018 1,892.00%
Jun 30, 2018 305.56%
Mar 31, 2018 40.45%
Dec 31, 2017 222.86%
Sep 30, 2017 86.56%
Jun 30, 2017 28.36%
Mar 31, 2017 -109.90%
Dec 31, 2016 -537.50%
Sep 30, 2016 56.24%
Jun 30, 2016 -443.24%
Mar 31, 2016 -48.84%
Dec 31, 2015 14.29%
Sep 30, 2015 -717.31%
Jun 30, 2015 38.33%
Mar 31, 2015 -3.20%
Dec 31, 2014 153.85%
Sep 30, 2014 13.33%
Jun 30, 2014 40.59%
Mar 31, 2014 -12.61%
Dec 31, 2013 69.41%
Sep 30, 2013 65.32%
Jun 30, 2013 31.29%
Mar 31, 2013 27.92%
Dec 31, 2012 30.36%
Sep 30, 2012 -30.29%
Jun 30, 2012 -99.54%
Mar 31, 2012 -29.96%
Dec 31, 2011 -24.17%
Sep 30, 2011 -1.47%
Jun 30, 2011 35.61%